Effects of desloratadine citrate disodium injection on rat models of ovalbumin-induced allergic rhinitis: involvement of T-cell responses modulation.

Author: GhoshArijit, HeGuangwei, JieQiong, WuYulin, YuanXin

Paper Details 
Original Abstract of the Article :
Allergic rhinitis (AR) is a very common worldwide problem; patients display a number of symptoms, such as sneezing, nasal itching, and rhinorrhea, and their lifestyle is affected. Desloratadine is a novel, long-acting inhibitor of histamine. However, very little is known about the effect of deslorat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/alr.21594

データ提供:米国国立医学図書館(NLM)

Unveiling the Secrets of Desloratadine: A New Path Through the Desert of Allergic Rhinitis

Allergic rhinitis, a common and often bothersome condition, can be a constant source of discomfort. This research delves into the effects of desloratadine citrate disodium injection (DLC injection) on a rat model of ovalbumin-induced allergic rhinitis, investigating its potential for treating this condition.

The authors explored the mechanisms of action of DLC injection, examining its impact on immune responses in a rat model of allergic rhinitis. The results suggest that DLC injection can effectively reduce allergic symptoms by modulating T-cell responses, offering a potential new avenue for treating this condition.

A New Oasis in the Desert of Allergic Rhinitis: Desloratadine's Potential

This research highlights the promising potential of desloratadine citrate disodium injection in treating allergic rhinitis. The authors demonstrate its efficacy in reducing allergic symptoms by modulating T-cell responses, offering a potential new weapon in the fight against this common condition.

A New Approach to Allergic Rhinitis Treatment

This research sheds light on the potential of desloratadine citrate disodium injection as a novel treatment for allergic rhinitis. It suggests that this approach, by modulating T-cell responses, may offer a more effective and targeted approach to managing this condition. This research, like the discovery of a new and refreshing oasis in a parched desert, offers hope for patients seeking relief from the discomfort of allergic rhinitis.

Dr. Camel's Conclusion

This research delves into the potential of desloratadine citrate disodium injection as a novel treatment for allergic rhinitis. The authors explore its mechanisms of action and demonstrate its efficacy in reducing allergic symptoms by modulating T-cell responses. This discovery, like finding a hidden oasis in a vast and unforgiving desert, offers hope for patients seeking relief from the discomfort of allergic rhinitis.

Date :
  1. Date Completed 2016-10-19
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26155922

DOI: Digital Object Identifier

10.1002/alr.21594

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.